2 Minute Medicine Rewind December 11, 2018
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer The risk of venous thromboembolism (VTE) is significantly increased in patients ...
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer The risk of venous thromboembolism (VTE) is significantly increased in patients ...
1. In this retrospective cohort study, rivaroxaban had the highest and apixaban had the lowest upper gastrointestinal bleeding (UGIB) risk. ...
1. Prophylactic low-molecular-weight heparin (LMWH) for 8 days post knee arthroscopy demonstrated no change in the incidence of venous thromboembolism ...
1. Based on a matched control study of elderly patients for whom anticoagulation was indicated, bleeding risk was mildly higher ...
1. Patients with atrial fibrillation are at higher risk of ischemic stroke and systemic embolism. 2. Compared to placebo, warfarin ...
1. Patients with atrial fibrillation are often treated with long-term oral anticoagulation, and may require interruption of their anticoagulation for ...
1. In patients requiring percutaneous coronary intervention (PCI) and long-term oral anticoagulation, treating with clopidogrel alone (i.e., double therapy) significantly ...
1. Meta-analysis suggests that there is no difference in risk of access site hematoma, bleeding complication, or mortality between interrupted ...
1. In a randomized controlled trial of over 300 patients with advanced pancreatic cancer treated in the outpatient setting, the ...
1. Anticoagulated patients with soft tissue bleeding can successfully be treated with arterial embolization with a high degree of technical ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.